These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1193 related articles for article (PubMed ID: 18942885)

  • 1. Inflammatory and coagulation biomarkers and mortality in patients with HIV infection.
    Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Neuhaus J; Nixon D; Paton NI; Neaton JD;
    PLoS Med; 2008 Oct; 5(10):e203. PubMed ID: 18942885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pre-ART levels of inflammation and coagulation markers are strong predictors of death in a South African cohort with advanced HIV disease.
    Ledwaba L; Tavel JA; Khabo P; Maja P; Qin J; Sangweni P; Liu X; Follmann D; Metcalf JA; Orsega S; Baseler B; Neaton JD; Lane HC;
    PLoS One; 2012; 7(3):e24243. PubMed ID: 22448211
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in inflammatory and coagulation biomarkers: a randomized comparison of immediate versus deferred antiretroviral therapy in patients with HIV infection.
    Baker JV; Neuhaus J; Duprez D; Kuller LH; Tracy R; Belloso WH; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon DE; Paton NI; Neaton JD;
    J Acquir Immune Defic Syndr; 2011 Jan; 56(1):36-43. PubMed ID: 20930640
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severity of cardiovascular disease outcomes among patients with HIV is related to markers of inflammation and coagulation.
    Nordell AD; McKenna M; Borges ÁH; Duprez D; Neuhaus J; Neaton JD; ;
    J Am Heart Assoc; 2014 May; 3(3):e000844. PubMed ID: 24870935
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Biomarkers and electrocardiographic evidence of myocardial ischemia in patients with human immunodeficiency virus infection.
    Gupta M; Miller CJ; Baker JV; Lazar J; Bogner JR; Calmy A; Soliman EZ; Neaton JD;
    Am J Cardiol; 2013 Mar; 111(5):760-4. PubMed ID: 23276469
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Higher levels of CRP, D-dimer, IL-6, and hyaluronic acid before initiation of antiretroviral therapy (ART) are associated with increased risk of AIDS or death.
    Boulware DR; Hullsiek KH; Puronen CE; Rupert A; Baker JV; French MA; Bohjanen PR; Novak RM; Neaton JD; Sereti I;
    J Infect Dis; 2011 Jun; 203(11):1637-46. PubMed ID: 21592994
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Activation and coagulation biomarkers are independent predictors of the development of opportunistic disease in patients with HIV infection.
    Rodger AJ; Fox Z; Lundgren JD; Kuller LH; Boesecke C; Gey D; Skoutelis A; Goetz MB; Phillips AN;
    J Infect Dis; 2009 Sep; 200(6):973-83. PubMed ID: 19678756
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effect of short-course antiretroviral therapy initiated in primary HIV-1 infection on interleukin-6 and D-dimer levels.
    Hamlyn E; Stöhr W; Cooper DA; Fisher M; Tambussi G; Schechter M; Miro JM; Vanobberghen F; Babiker A; Weber J; Mcclure M; Porter K; Fidler S;
    AIDS; 2015 Jul; 29(11):1355-61. PubMed ID: 25870986
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Do Biomarkers of Inflammation, Monocyte Activation, and Altered Coagulation Explain Excess Mortality Between HIV Infected and Uninfected People?
    So-Armah KA; Tate JP; Chang CH; Butt AA; Gerschenson M; Gibert CL; Leaf D; Rimland D; Rodriguez-Barradas MC; Budoff MJ; Samet JH; Kuller LH; Deeks SG; Crothers K; Tracy RP; Crane HM; Sajadi MM; Tindle HA; Justice AC; Freiberg MS;
    J Acquir Immune Defic Syndr; 2016 Jun; 72(2):206-213. PubMed ID: 27824677
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Monocyte-activation phenotypes are associated with biomarkers of inflammation and coagulation in chronic HIV infection.
    Wilson EM; Singh A; Hullsiek KH; Gibson D; Henry WK; Lichtenstein K; Önen NF; Kojic E; Patel P; Brooks JT; Sereti I; Baker JV;
    J Infect Dis; 2014 Nov; 210(9):1396-406. PubMed ID: 24813472
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pre-therapy inflammation and coagulation activation and long-term CD4 count responses to the initiation of antiretroviral therapy.
    Achhra AC; Phillips A; Emery S; MacArthur RD; Furrer H; De Wit S; Losso M; Law MG;
    HIV Med; 2015 Aug; 16(7):449-54. PubMed ID: 25959989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biomarkers and bacterial pneumonia risk in patients with treated HIV infection: a case-control study.
    Bjerk SM; Baker JV; Emery S; Neuhaus J; Angus B; Gordin FM; Pett SL; Stephan C; Kunisaki KM;
    PLoS One; 2013; 8(2):e56249. PubMed ID: 23457535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Relevance of Interleukin-6 and D-Dimer for Serious Non-AIDS Morbidity and Death among HIV-Positive Adults on Suppressive Antiretroviral Therapy.
    Grund B; Baker JV; Deeks SG; Wolfson J; Wentworth D; Cozzi-Lepri A; Cohen CJ; Phillips A; Lundgren JD; Neaton JD;
    PLoS One; 2016; 11(5):e0155100. PubMed ID: 27171281
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Interleukin-2 cycling causes transient increases in high-sensitivity C-reactive protein and D-dimer that are not associated with plasma HIV-RNA levels.
    Porter BO; Shen J; Kovacs JA; Davey RT; Rehm C; Lozier J; Csako G; Nghiem K; Costello R; Lane HC; Sereti I
    AIDS; 2009 Sep; 23(15):2015-9. PubMed ID: 19617815
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet count kinetics following interruption of antiretroviral treatment.
    Zetterberg E; Neuhaus J; Baker JV; Somboonwit C; Llibre JM; Palfreeman A; Chini M; Lundgren JD;
    AIDS; 2013 Jan; 27(1):59-68. PubMed ID: 23018440
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inflammatory biomarkers and abacavir use in the Women's Interagency HIV Study and the Multicenter AIDS Cohort Study.
    Palella FJ; Gange SJ; Benning L; Jacobson L; Kaplan RC; Landay AL; Tracy RP; Elion R
    AIDS; 2010 Jul; 24(11):1657-65. PubMed ID: 20588104
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Markers of inflammation, coagulation, and renal function are elevated in adults with HIV infection.
    Neuhaus J; Jacobs DR; Baker JV; Calmy A; Duprez D; La Rosa A; Kuller LH; Pett SL; Ristola M; Ross MJ; Shlipak MG; Tracy R; Neaton JD
    J Infect Dis; 2010 Jun; 201(12):1788-95. PubMed ID: 20446848
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Inflammation, coagulation and cardiovascular disease in HIV-infected individuals.
    Duprez DA; Neuhaus J; Kuller LH; Tracy R; Belloso W; De Wit S; Drummond F; Lane HC; Ledergerber B; Lundgren J; Nixon D; Paton NI; Prineas RJ; Neaton JD;
    PLoS One; 2012; 7(9):e44454. PubMed ID: 22970224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Decreases in inflammatory and coagulation biomarkers levels in HIV-infected patients switching from enfuvirtide to raltegravir: ANRS 138 substudy.
    Silva EF; Charreau I; Gourmel B; Mourah S; Kalidi I; Guillon B; De Castro N; Caron F; Braun J; Molina JM;
    J Infect Dis; 2013 Sep; 208(6):892-7. PubMed ID: 23801606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Predicting risk of cancer during HIV infection: the role of inflammatory and coagulation biomarkers.
    Borges ÁH; Silverberg MJ; Wentworth D; Grulich AE; Fätkenheuer G; Mitsuyasu R; Tambussi G; Sabin CA; Neaton JD; Lundgren JD; ; ;
    AIDS; 2013 Jun; 27(9):1433-41. PubMed ID: 23945504
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 60.